Opinion

Video

Role of Testing in Treatment Decisions - ClonoSeq, PhaseSeq, MRD+Disease

A concise discussion of second-line treatment strategies for DLBCL, highlighting preferred regimens for transplant-eligible and ineligible patients, as well as treatment approaches based on the timing of relapse.

Video content above is prompted by the following:

Briefly discuss second-line (2L) treatment of DLBCL.

  • What are preferred regimens for transplant ineligible versus transplant eligible?
  • What are preferred regimens for patients that relapse within 12 months versus those that do not progress within 12 months?
Related Videos
3 experts are featured in this series.
3 experts are featured in this series.
5 experts are featured in this series